 | • レポートコード：20QY06-01858 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、コデインのグローバル市場について種類別（単一成分コデイン、複数成分薬）、用途別（麻薬性鎮痛剤、鎮痛剤、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・コデイン市場の概要 ・世界の主要地域別コデイン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のコデイン市場規模2015-2026：種類別（単一成分コデイン、複数成分薬） ・世界のコデイン市場規模2015-2026：用途別（麻薬性鎮痛剤、鎮痛剤、その他） ・コデインの北米市場規模2015-2020 ・コデインのヨーロッパ市場規模2015-2020 ・コデインの中国市場規模2015-2020 ・コデインの日本市場規模2015-2020 ・コデインの東南アジア市場規模2015-2020 ・コデインのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Taiji、Mallinckrodt、TEVA、Johnson & Johnson、Medreich、Sanofi Aventis、Cipla、Hikma、Pharmaceutical Associates、Novartis、Apotex、Mylan、Aristo Pharma GmbH、Lannett Company、Laboratoire Riva） ・コデインの製造コスト分析 ・販売チャネル、流通業者、顧客 ・コデインの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Codeine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Codeine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Codeine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Codeine industry.
Based on our recent survey, we have several different scenarios about the Codeine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 313 million in 2019. The market size of Codeine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Codeine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Codeine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Codeine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Codeine market. The report also includes nautical information, where it shows Codeine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Codeine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Codeine market.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
Geographical Analysis:
Based on region, the global Codeine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Codeine market are
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Codeine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Codeine market.
• The market share of the global Codeine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Codeine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Codeine market.
1 Codeine Market Overview
1.1 Codeine Product Scope
1.2 Codeine Segment by Type
1.2.1 Global Codeine Sales by Type (2020-2026)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Codeine Segment by Application
1.3.1 Global Codeine Sales Comparison by Application (2020-2026)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Codeine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Codeine Sales Growth Rate (2015-2026)
1.4.2 Global Codeine Revenue and Growth Rate (2015-2026)
1.4.3 Global Codeine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Codeine Industry Impact
1.5.1 How the Covid-19 is Affecting the Codeine Industry
1.5.1.1 Codeine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Codeine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Codeine Players to Combat Covid-19 Impact
2 Codeine Estimate and Forecast by Region
2.1 Global Codeine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Codeine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Codeine Sales Market Share by Region (2015-2020)
2.2.2 Global Codeine Revenue Market Share by Region (2015-2020)
2.3 Global Codeine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Codeine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Codeine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Codeine Estimates and Projections (2015-2026)
2.4.2 Europe Codeine Estimates and Projections (2015-2026)
2.4.3 China Codeine Estimates and Projections (2015-2026)
2.4.4 Japan Codeine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Codeine Estimates and Projections (2015-2026)
2.4.6 India Codeine Estimates and Projections (2015-2026)
3 Global Codeine Competition Landscape by Players
3.1 Global Top Codeine Players by Sales (2015-2020)
3.2 Global Top Codeine Players by Revenue (2015-2020)
3.3 Global Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Codeine as of 2019)
3.4 Global Codeine Average Price by Company (2015-2020)
3.5 Manufacturers Codeine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Codeine Players (Opinion Leaders)
4 Global Codeine Market Size by Type
4.1 Global Codeine Historic Market Review by Type (2015-2020)
4.1.1 Global Codeine Sales Market Share by Type (2015-2020)
4.1.2 Global Codeine Revenue Market Share by Type (2015-2020)
4.1.3 Global Codeine Price by Type (2014-2020)
4.2 Global Codeine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Codeine Sales Forecast by Type (2021-2026)
4.2.2 Global Codeine Revenue Forecast by Type (2021-2026)
4.2.3 Global Codeine Price Forecast by Type (2021-2026)
5 Global Codeine Market Size by Application
5.1 Global Codeine Historic Market Review by Application (2015-2020)
5.1.1 Global Codeine Sales Market Share by Application (2015-2020)
5.1.2 Global Codeine Revenue Market Share by Application (2015-2020)
5.1.3 Global Codeine Price by Application (2015-2020)
5.2 Global Codeine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Codeine Sales Forecast by Application (2021-2026)
5.2.2 Global Codeine Revenue Forecast by Application (2021-2026)
5.2.3 Global Codeine Price Forecast by Application (2021-2026)
3 North America Codeine Market Facts & Figures
3.2 North America Codeine Sales Market Share by Company (2015-2020)
3.3 North America Codeine Sales Market Share by Type (2015-2020)
3.4 North America Codeine Sales Market Share by Application (2015-2020)
4 Europe Codeine Market Facts & Figures
4.2 Europe Codeine Sales Market Share by Company (2015-2020)
4.3 Europe Codeine Sales Market Share by Type (2015-2020)
4.4 Europe Codeine Sales Market Share by Application (2015-2020)
5 China Codeine Market Facts & Figures
5.2 China Codeine Sales Market Share by Company (2015-2020)
5.3 China Codeine Sales Market Share by Type (2015-2020)
5.4 China Codeine Sales Market Share by Application (2015-2020)
6 Japan Codeine Market Facts & Figures
6.2 Japan Codeine Sales Market Share by Company (2015-2020)
6.3 Japan Codeine Sales Market Share by Type (2015-2020)
6.4 Japan Codeine Sales Market Share by Application (2015-2020)
7 Southeast Asia Codeine Market Facts & Figures
7.2 Southeast Asia Codeine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Codeine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Codeine Sales Market Share by Application (2015-2020)
8 India Codeine Market Facts & Figures
8.2 India Codeine Sales Market Share by Company (2015-2020)
8.3 India Codeine Sales Market Share by Type (2015-2020)
8.4 India Codeine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Codeine Business
12.1 Taiji
12.1.1 Taiji Codeine Corporation Information
12.1.2 Taiji Codeine Business Overview and Total Revenue
12.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Taiji Codeine Products Offered
12.1.5 Taiji Recent Development
12.2 Mallinckrodt
12.2.1 Mallinckrodt Codeine Corporation Information
12.2.2 Mallinckrodt Codeine Business Overview and Total Revenue
12.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mallinckrodt Codeine Products Offered
12.2.5 Mallinckrodt Recent Development
12.3 TEVA
12.3.1 TEVA Codeine Corporation Information
12.3.2 TEVA Codeine Business Overview and Total Revenue
12.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 TEVA Codeine Products Offered
12.3.5 TEVA Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Codeine Corporation Information
12.4.2 Johnson & Johnson Codeine Business Overview and Total Revenue
12.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Codeine Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Medreich
12.5.1 Medreich Codeine Corporation Information
12.5.2 Medreich Codeine Business Overview and Total Revenue
12.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Medreich Codeine Products Offered
12.5.5 Medreich Recent Development
12.6 Sanofi Aventis
12.6.1 Sanofi Aventis Codeine Corporation Information
12.6.2 Sanofi Aventis Codeine Business Overview and Total Revenue
12.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi Aventis Codeine Products Offered
12.6.5 Sanofi Aventis Recent Development
12.7 Cipla
12.7.1 Cipla Codeine Corporation Information
12.7.2 Cipla Codeine Business Overview and Total Revenue
12.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Cipla Codeine Products Offered
12.7.5 Cipla Recent Development
12.8 Hikma
12.8.1 Hikma Codeine Corporation Information
12.8.2 Hikma Codeine Business Overview and Total Revenue
12.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hikma Codeine Products Offered
12.8.5 Hikma Recent Development
12.9 Pharmaceutical Associates
12.9.1 Pharmaceutical Associates Codeine Corporation Information
12.9.2 Pharmaceutical Associates Codeine Business Overview and Total Revenue
12.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Pharmaceutical Associates Codeine Products Offered
12.9.5 Pharmaceutical Associates Recent Development
12.10 Novartis
12.10.1 Novartis Codeine Corporation Information
12.10.2 Novartis Codeine Business Overview and Total Revenue
12.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis Codeine Products Offered
12.10.5 Novartis Recent Development
12.11 Apotex
12.11.1 Apotex Codeine Corporation Information
12.11.2 Apotex Codeine Business Overview and Total Revenue
12.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Apotex Codeine Products Offered
12.11.5 Apotex Recent Development
12.12 Mylan
12.12.1 Mylan Codeine Corporation Information
12.12.2 Mylan Codeine Business Overview and Total Revenue
12.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Mylan Codeine Products Offered
12.12.5 Mylan Recent Development
12.13 Aristo Pharma GmbH
12.13.1 Aristo Pharma GmbH Codeine Corporation Information
12.13.2 Aristo Pharma GmbH Codeine Business Overview and Total Revenue
12.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Aristo Pharma GmbH Codeine Products Offered
12.13.5 Aristo Pharma GmbH Recent Development
12.14 Lannett Company
12.14.1 Lannett Company Codeine Corporation Information
12.14.2 Lannett Company Codeine Business Overview and Total Revenue
12.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Lannett Company Codeine Products Offered
12.14.5 Lannett Company Recent Development
12.15 Laboratoire Riva
12.15.1 Laboratoire Riva Codeine Corporation Information
12.15.2 Laboratoire Riva Codeine Business Overview and Total Revenue
12.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Laboratoire Riva Codeine Products Offered
12.15.5 Laboratoire Riva Recent Development
13 Codeine Manufacturing Cost Analysis
13.1 Codeine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Codeine
13.4 Codeine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Codeine Distributors List
14.3 Codeine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Codeine Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Codeine Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Codeine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Codeine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Codeine Players to Combat Covid-19 Impact
Table 8. Global Market Codeine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Codeine Sales (M Units) by Region (2015-2020)
Table 10. Global Codeine Sales Market Share by Region (2015-2020)
Table 11. Global Codeine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Codeine Revenue Share by Region (2015-2020)
Table 13. Global Codeine Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Codeine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Codeine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Codeine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Codeine (M Units) of Key Companies (2015-2020)
Table 18. Global Codeine Sales Share by Company (2015-2020)
Table 19. Global Codeine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Codeine Revenue Share by Company (2015-2020)
Table 21. Global Codeine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Codeine as of 2019)
Table 22. Global Codeine Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Codeine Manufacturing Sites and Area Served
Table 24. Manufacturers Codeine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Codeine Players
Table 27. Global Codeine Sales (M Units) by Type (2015-2020)
Table 28. Global Codeine Sales Share by Type (2015-2020)
Table 29. Global Codeine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Codeine Price (M Units) by Type (2015-2020)
Table 31. Global Codeine Sales Share by Type (2021-2026)
Table 32. Global Codeine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Codeine Revenue Share by Type (2021-2026)
Table 34. Global Codeine Price (M Units) by Type (2021-2026)
Table 35. Global Codeine Sales (M Units) by Application (2015-2020)
Table 36. Global Codeine Sales Share by Application (2015-2020)
Table 37. Global Codeine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Codeine Price (M Units) by Application (2015-2020)
Table 39. Global Codeine Sales (M Units) by Application (2021-2026)
Table 40. Global Codeine Sales Share by Application (2021-2026)
Table 41. Global Codeine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Codeine Revenue Share by Application (2021-2026)
Table 43. Global Codeine Price (M Units) by Application (2021-2026)
Table 44. United States Codeine Sales (M Units) by Company (2015-2020)
Table 45. United States Codeine Sales Market Share by Company (2015-2020)
Table 46. United States Codeine Sales (M Units) by Type (2015-2020)
Table 47. United States Codeine Sales Market Share by Type (2015-2020)
Table 48. United States Codeine Sales (M Units) by Application (2015-2020)
Table 49. United States Codeine Sales Market Share by Application (2015-2020)
Table 50. Europe Codeine Sales (M Units) by Company (2015-2020)
Table 51. Europe Codeine Sales Market Share by Company (2015-2020)
Table 52. Europe Codeine Sales (M Units) by Type (2015-2020)
Table 53. Europe Codeine Sales Market Share by Type (2015-2020)
Table 54. Europe Codeine Sales (M Units) by Application (2015-2020)
Table 55. Europe Codeine Sales Market Share by Type (2015-2020)
Table 56. China Codeine Sales (M Units) by Company (2015-2020)
Table 57. China Codeine Sales Market Share by Company (2015-2020)
Table 58. China Codeine Sales (M Units) by Type (2015-2020)
Table 59. China Codeine Sales Market Share by Type (2015-2020)
Table 60. China Codeine Sales (M Units) by Application (2015-2020)
Table 61. China Codeine Sales Market Share by Application (2015-2020)
Table 62. Japan Codeine Sales (M Units) by Company (2015-2020)
Table 63. Japan Codeine Sales Market Share by Company (2015-2020)
Table 64. Japan Codeine Sales (M Units) by Type (2015-2020)
Table 65. Japan Codeine Sales Market Share by Type (2015-2020)
Table 66. Japan Codeine Sales (M Units) by Application (2015-2020)
Table 67. Japan Codeine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Codeine Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Codeine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Codeine Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Codeine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Codeine Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Codeine Sales Market Share by Application (2015-2020)
Table 74. India Codeine Sales (M Units) by Company (2015-2020)
Table 75. India Codeine Sales Market Share by Company (2015-2020)
Table 76. India Codeine Sales (M Units) by Type (2015-2020)
Table 77. India Codeine Sales Market Share by Type (2015-2020)
Table 78. India Codeine Sales (M Units) by Application (2015-2020)
Table 79. India Codeine Sales Market Share by Application (2015-2020)
Table 80. Taiji Corporation Information
Table 81. Taiji Description and Business Overview
Table 82. Taiji Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Taiji Codeine Product
Table 84. Taiji Recent Development
Table 85. Mallinckrodt Corporation Information
Table 86. Mallinckrodt Description and Business Overview
Table 87. Mallinckrodt Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Mallinckrodt Codeine Product
Table 89. Mallinckrodt Recent Development
Table 90. TEVA Corporation Information
Table 91. TEVA Description and Business Overview
Table 92. TEVA Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. TEVA Codeine Product
Table 94. TEVA Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Codeine Product
Table 99. Johnson & Johnson Recent Development
Table 100. Medreich Corporation Information
Table 101. Medreich Description and Business Overview
Table 102. Medreich Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Medreich Codeine Product
Table 104. Medreich Recent Development
Table 105. Sanofi Aventis Corporation Information
Table 106. Sanofi Aventis Description and Business Overview
Table 107. Sanofi Aventis Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sanofi Aventis Codeine Product
Table 109. Sanofi Aventis Recent Development
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Cipla Codeine Product
Table 114. Cipla Recent Development
Table 115. Hikma Corporation Information
Table 116. Hikma Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Hikma Description and Business Overview
Table 118. Hikma Codeine Product
Table 119. Hikma Recent Development
Table 120. Pharmaceutical Associates Corporation Information
Table 121. Pharmaceutical Associates Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Pharmaceutical Associates Description and Business Overview
Table 123. Pharmaceutical Associates Codeine Product
Table 124. Pharmaceutical Associates Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Novartis Codeine Product
Table 129. Novartis Recent Development
Table 130. Apotex Corporation Information
Table 131. Apotex Description and Business Overview
Table 132. Apotex Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Apotex Codeine Product
Table 134. Apotex Recent Development
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Business Overview
Table 137. Mylan Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Mylan Codeine Product
Table 139. Mylan Recent Development
Table 140. Aristo Pharma GmbH Corporation Information
Table 141. Aristo Pharma GmbH Description and Business Overview
Table 142. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Aristo Pharma GmbH Codeine Product
Table 144. Aristo Pharma GmbH Recent Development
Table 145. Lannett Company Corporation Information
Table 146. Lannett Company Description and Business Overview
Table 147. Lannett Company Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Lannett Company Codeine Product
Table 149. Lannett Company Recent Development
Table . Laboratoire Riva Corporation Information
Table . Laboratoire Riva Description and Business Overview
Table . Laboratoire Riva Codeine Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Laboratoire Riva Codeine Product
Table . Laboratoire Riva Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Codeine Distributors List
Table 158. Codeine Customers List
Table 159. Market Key Trends
Table 160. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 161. Key Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Codeine Product Picture
Figure 2. Global Codeine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Codeine Market Share by Application in 2020 & 2026
Figure 6. Narcotic Analgesic Examples
Figure 7. Antitussive Examples
Figure 8. Others Examples
Figure 9. Global Codeine Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Codeine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Codeine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Codeine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Codeine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Codeine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Codeine Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Codeine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Codeine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Codeine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Codeine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Codeine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Codeine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Codeine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Codeine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Codeine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Codeine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Codeine Players Market Share by Revenue in Codeine 2015 & 2019
Figure 27. Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Codeine Revenue Share by Type (2015-2020)
Figure 29. Global Codeine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Codeine Revenue Share by Application (2015-2020)
Figure 31. Global Codeine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Codeine Sales Market Share by Type in 2019
Figure 33. United States Codeine Sales Market Share by Type in 2019
Figure 34. Europe Codeine Sales Market Share by Company in 2019
Figure 35. Europe Codeine Sales Market Share by Type in 2019
Figure 36. Europe Codeine Sales Market Share by Application in 2019
Figure 37. China Codeine Sales Market Share by Company in 2019
Figure 38. China Codeine Sales Market Share by Type in 2019
Figure 39. China Codeine Sales Market Share by Application in 2019
Figure 40. Japan Codeine Sales Market Share by Company in 2019
Figure 41. Japan Codeine Sales Market Share by Type in 2019
Figure 42. Japan Codeine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Codeine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Codeine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Codeine Sales Market Share by Application in 2019
Figure 46. India Codeine Sales Market Share by Company in 2019
Figure 47. India Codeine Sales Market Share by Type in 2019
Figure 48. India Codeine Sales Market Share by Application in 2019
Figure 49. Taiji Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Medreich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sanofi Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Pharmaceutical Associates Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Aristo Pharma GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Lannett Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Laboratoire Riva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Codeine
Figure 66. Manufacturing Process Analysis of Codeine
Figure 67. Codeine Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
オピオイド薬の世界市場レポート2020 Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact wit…- イミュニティ栄養補助食品成分の世界市場レポート2020 Market Analysis and Insights: Global Immunity Nutraceutical Ingredient Market The global Immunity Nutraceutical Ingredient market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Immunity Nutraceutical Ingredient…
- 食品成分の世界市場レポート2020 Market Analysis and Insights: Global Food Ingredient Market The global Food Ingredient market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Food Ingredient Scope and Market Size The global Food Ingredient mark…
- オピオイド作動薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioids Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 18590 million by 2025, from USD 16980 million in 2019. The Opioids Agonist …
- 食品成分分析装置の世界市場レポート2020 A recently published report by QY Research titled Global Food Ingredient Analysis Equipment Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically p…